Effective Treatment of Neurological Symptoms with Normal Doses of Botulinum Neurotoxin in Wilson’s Disease: Six Cases and Literature Review

Recent cell-based and animal experiments have demonstrated an effective reduction in botulinum neurotoxin A (BoNT/A) by copper. Aim: We aimed to analyze whether the successful symptomatic BoNT/A treatment of patients with Wilson’s disease (WD) corresponds with unusually high doses per session. Among...

Descripción completa

Detalles Bibliográficos
Autores principales: Hefter, Harald, Samadzadeh, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065630/
https://www.ncbi.nlm.nih.gov/pubmed/33805281
http://dx.doi.org/10.3390/toxins13040241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065630/
https://www.ncbi.nlm.nih.gov/pubmed/33805281
http://dx.doi.org/10.3390/toxins13040241

Ejemplares similares